NuCana (NCNA) Interest Coverage Ratio (2020 - 2025)
NuCana (NCNA) reported Interest Coverage Ratio of 0.22 for Q4 2025, down 100.36% on a YoY basis from 61.79 in Q4 2024, and up 99.94% sequentially from 389.5 in Q3 2025.
NuCana (NCNA) Interest Coverage Ratio (2020 - 2025) Analysis & Trends
NuCana (NCNA) has 6 years of Interest Coverage Ratio data on file, last reported at 0.22 in Q4 2025.
- For the quarter ending Q4 2025, Interest Coverage Ratio fell 100.36% year-over-year to 0.22; the trailing twelve-month figure through Dec 2025 stood at 433.67 (down 99.82% YoY), and the FY2025 full-year result was 1.59, up 99.88% from the prior year.
- Interest Coverage Ratio climbed to 0.22 in Q4 2025, from 389.5 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 395.96 in Q4 2023 to a low of 5245.67 in Q4 2021.
- A 5-year average of 1507.22 and a median of 1330.75 in 2024 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio plunged 125.31% in 2021 and surged 100.06% in 2025, its largest moves.
- Tracing NCNA's Interest Coverage Ratio over 5 years: stood at 5245.67 in 2021, then surged by 50.26% to 2609.0 in 2022, then surged by 115.18% to 395.96 in 2023, then sank by 84.4% to 61.79 in 2024, then slumped by 100.36% to 0.22 in 2025.
- Business Quant data shows NCNA's Interest Coverage Ratio at 0.22 in Q4 2025, 389.5 in Q3 2025, and 0.94 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 3.88 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.22 |
| Sep 30, 2025 | -389.50 |
| Jun 30, 2025 | 0.94 |
| Dec 31, 2024 | 61.79 |
| Sep 30, 2024 | -1,330.75 |
| Jun 30, 2024 | -1,670.40 |
| Mar 31, 2024 | -1,653.80 |
| Dec 31, 2023 | 395.96 |
| Sep 30, 2023 | -1,178.86 |
| Jun 30, 2023 | -784.63 |
| Mar 31, 2023 | -1,143.50 |
| Jun 30, 2022 | -2,609.00 |
| Mar 31, 2022 | -3,489.00 |
| Dec 31, 2021 | -5,245.67 |
| Sep 30, 2021 | -1,994.80 |
| Jun 30, 2021 | -2,676.75 |
| Mar 31, 2021 | -1,914.50 |
| Dec 31, 2020 | -2,328.17 |
| Sep 30, 2020 | -1,604.00 |